|1.||McKillop, A M: 2 articles (02/2006 - 09/2000)|
|2.||Flatt, P R: 2 articles (02/2006 - 09/2000)|
|3.||Devi, Vishalakshiamma Girija: 1 article (11/2015)|
|4.||Rajamohan, Thankappan: 1 article (11/2015)|
|5.||Preetha, Prabhakaran Prabha: 1 article (11/2015)|
|6.||Mini, S: 1 article (08/2014)|
|7.||Divya, B T: 1 article (08/2014)|
|8.||Gulati, Seema: 1 article (02/2014)|
|9.||Misra, Anoop: 1 article (02/2014)|
|10.||Saluja, Shelza: 1 article (02/2014)|
02/01/2006 - "There is mounting evidence that elevated circulating concentrations of glycated insulin play a role in insulin resistance in type 2 diabetes. "
01/01/2013 - "A non-European ethnic origin, low socio-economic and integration scores, conduced higher OR for belonging to clusters 1, 2, and 3 as compared to cluster 4. Significant differences in fasting and 2-h glucose, fasting insulin, glycosylated haemoglobin (HbA1c), insulin resistance (HOMA-IR), and total cholesterol were observed across the dietary patterns. "
04/21/2004 - "Factors included levels of fasting and postload glucose and insulin, glycosylated hemoglobin (HbA1c), and lipids, as well as insulin resistance measured by homeostasis model assessment (HOMA-IR). "
10/01/2008 - "Body mass index, waist and hip circumference, body fat percentage, fasting blood glucose, insulin, glycosylated hemoglobin, homeostasis model assesement of insulin resistance, alanine transaminase, aspartate tarnsaminase, and leptin levels were significantly higher in the study group than in controls. "
01/01/2014 - "Total cholesterol (TC), low- (LDL-C) and high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting plasma glucose, insulin, glycosylated haemoglobin A1c (HbA1c) and high sensitivity C-reactive protein (hsCRP) levels were measured, and homeostatic model of assessment insulin resistance (HOMA-IR) was calculated at baseline and 12 weeks post-treatment. "
|3.||Body Weight (Weight, Body)
06/01/2000 - "No differences were found between groups 2 and 3. With simple regression analysis, ET-1 levels significantly correlated with insulin, glycosylated hemoglobin, body weight, waist to hip ratio, and triglyceride values. "
12/01/1997 - "Glucose-lowering activities of glycated and control (non-glycated) insulin preparations were assessed in mice by intraperitoneal injection in a 39% (w/v) glucose solution (2 g/kg body weight) at doses of 0.05 and 0.25 units/kg body weight. "
01/01/2003 - "Blood glucose, plasma insulin, glycosylated hemoglobin, liver glycogen, and change in body weight were determined. "
02/01/2014 - "Body weight, waist circumference (WC), magnetic resonance imaging estimation of intraabdominal adipose tissue and subcutaneous abdominal adipose tissue, fasting blood glucose (FBG), fasting serum insulin, glycosylated hemoglobin, lipid profile, high-sensitivity C-reactive protein (hs-CRP), adiponectin, free fatty acids (FFAs), tumor necrosis factor (TNF)-α, leptin, and thiobarbituric acid reactive substances (TBARS) were assessed before and after the intervention. "
09/01/2000 - "These data indicate that the impaired biological activity of glycated insulin may contribute to glucose intolerance of diabetes."
12/01/1997 - "These data indicate that glycated insulin exhibits impaired biological activity which may contribute to glucose intolerance in diabetes. "
02/01/2009 - "To assess the association between insulin resistance, glucose intolerance, essential hypertension, and subsequent development of proteinuric and nonproteinuric hypertension in pregnancy in women without underlying essential hypertension, we performed a prospective study comparing glucose (fasting, 1 and 2 hours postglucose load), insulin, glycosylated hemoglobin (HbA1c), high-density lipoprotein cholesterol (HDL-C), and triglycerides levels on routine screening for gestational diabetes mellitus. "
01/01/2012 - "Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody."
01/01/2013 - "A Cox regression model was applied to test for the associations between cancer mortality and fasting serum glucose, insulin, glycosylated hemoglobin (HbA1c), C-peptide, insulin like growth factor (IGF-1), IGF binding protein 3 (IGFBP3) and estimated insulin resistance. "
|2.||Blood Glucose (Blood Sugar)
|4.||Alanine Transaminase (SGPT)
|5.||Aspartic Acid (Aspartate)